nodes	percent_of_prediction	percent_of_DWPC	metapath
Eletriptan—Sensation of warmth—Hydrochlorothiazide—nephrolithiasis	0.038	0.0552	CcSEcCtD
Eletriptan—Anorectal disorder—Hydrochlorothiazide—nephrolithiasis	0.0195	0.0283	CcSEcCtD
Eletriptan—Creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.0195	0.0283	CcSEcCtD
Eletriptan—Blood creatine phosphokinase increased—Hydrochlorothiazide—nephrolithiasis	0.0149	0.0216	CcSEcCtD
Eletriptan—Ventricular arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.0138	0.0201	CcSEcCtD
Eletriptan—Ventricular fibrillation—Hydrochlorothiazide—nephrolithiasis	0.0134	0.0194	CcSEcCtD
Eletriptan—Feeling hot—Hydrochlorothiazide—nephrolithiasis	0.0131	0.0189	CcSEcCtD
Eletriptan—HTR1F—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0124	0.0436	CbGpPWpGaD
Eletriptan—Numbness—Hydrochlorothiazide—nephrolithiasis	0.0124	0.0179	CcSEcCtD
Eletriptan—Sensory loss—Hydrochlorothiazide—nephrolithiasis	0.0118	0.0171	CcSEcCtD
Eletriptan—HTR1E—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0117	0.0412	CbGpPWpGaD
Eletriptan—Bone pain—Hydrochlorothiazide—nephrolithiasis	0.0107	0.0155	CcSEcCtD
Eletriptan—Coordination abnormal—Hydrochlorothiazide—nephrolithiasis	0.0104	0.0151	CcSEcCtD
Eletriptan—HTR1F—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0104	0.0367	CbGpPWpGaD
Eletriptan—Ventricular tachycardia—Hydrochlorothiazide—nephrolithiasis	0.0102	0.0149	CcSEcCtD
Eletriptan—HTR1E—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.0098	0.0346	CbGpPWpGaD
Eletriptan—Oesophagitis—Hydrochlorothiazide—nephrolithiasis	0.00936	0.0136	CcSEcCtD
Eletriptan—Urine output increased—Hydrochlorothiazide—nephrolithiasis	0.00926	0.0134	CcSEcCtD
Eletriptan—Sleep disorder—Hydrochlorothiazide—nephrolithiasis	0.00859	0.0125	CcSEcCtD
Eletriptan—Polyuria—Hydrochlorothiazide—nephrolithiasis	0.00847	0.0123	CcSEcCtD
Eletriptan—Vascular purpura—Hydrochlorothiazide—nephrolithiasis	0.00831	0.0121	CcSEcCtD
Eletriptan—Injury—Hydrochlorothiazide—nephrolithiasis	0.00809	0.0117	CcSEcCtD
Eletriptan—HTR7—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00796	0.0281	CbGpPWpGaD
Eletriptan—Increased appetite—Hydrochlorothiazide—nephrolithiasis	0.00791	0.0115	CcSEcCtD
Eletriptan—HTR1D—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0079	0.0279	CbGpPWpGaD
Eletriptan—Dermatitis exfoliative—Hydrochlorothiazide—nephrolithiasis	0.00788	0.0114	CcSEcCtD
Eletriptan—Atrial fibrillation—Hydrochlorothiazide—nephrolithiasis	0.00785	0.0114	CcSEcCtD
Eletriptan—Thirst—Hydrochlorothiazide—nephrolithiasis	0.00781	0.0113	CcSEcCtD
Eletriptan—HTR1B—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00774	0.0273	CbGpPWpGaD
Eletriptan—Purpura—Hydrochlorothiazide—nephrolithiasis	0.00771	0.0112	CcSEcCtD
Eletriptan—Arthritis—Hydrochlorothiazide—nephrolithiasis	0.00765	0.0111	CcSEcCtD
Eletriptan—Affect lability—Hydrochlorothiazide—nephrolithiasis	0.00732	0.0106	CcSEcCtD
Eletriptan—Migraine—Hydrochlorothiazide—nephrolithiasis	0.00732	0.0106	CcSEcCtD
Eletriptan—HTR2B—Monoamine GPCRs—CHRM3—nephrolithiasis	0.00727	0.0257	CbGpPWpGaD
Eletriptan—Face oedema—Hydrochlorothiazide—nephrolithiasis	0.00718	0.0104	CcSEcCtD
Eletriptan—Mood swings—Hydrochlorothiazide—nephrolithiasis	0.00704	0.0102	CcSEcCtD
Eletriptan—Ataxia—Hydrochlorothiazide—nephrolithiasis	0.00699	0.0101	CcSEcCtD
Eletriptan—Liver function test abnormal—Hydrochlorothiazide—nephrolithiasis	0.00686	0.00996	CcSEcCtD
Eletriptan—Dry skin—Hydrochlorothiazide—nephrolithiasis	0.00682	0.00988	CcSEcCtD
Eletriptan—Abdominal pain upper—Hydrochlorothiazide—nephrolithiasis	0.00679	0.00985	CcSEcCtD
Eletriptan—Cramp muscle—Hydrochlorothiazide—nephrolithiasis	0.0067	0.00971	CcSEcCtD
Eletriptan—HTR7—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00669	0.0236	CbGpPWpGaD
Eletriptan—HTR1D—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00664	0.0235	CbGpPWpGaD
Eletriptan—Gastritis—Hydrochlorothiazide—nephrolithiasis	0.00658	0.00954	CcSEcCtD
Eletriptan—Muscular weakness—Hydrochlorothiazide—nephrolithiasis	0.00656	0.00951	CcSEcCtD
Eletriptan—HTR1B—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00651	0.023	CbGpPWpGaD
Eletriptan—Abdominal distension—Hydrochlorothiazide—nephrolithiasis	0.00647	0.00938	CcSEcCtD
Eletriptan—Influenza—Hydrochlorothiazide—nephrolithiasis	0.00643	0.00932	CcSEcCtD
Eletriptan—Dysphagia—Hydrochlorothiazide—nephrolithiasis	0.00643	0.00932	CcSEcCtD
Eletriptan—Angina pectoris—Hydrochlorothiazide—nephrolithiasis	0.00626	0.00908	CcSEcCtD
Eletriptan—HTR2B—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00611	0.0216	CbGpPWpGaD
Eletriptan—Pollakiuria—Hydrochlorothiazide—nephrolithiasis	0.00594	0.00861	CcSEcCtD
Eletriptan—Erectile dysfunction—Hydrochlorothiazide—nephrolithiasis	0.00592	0.00858	CcSEcCtD
Eletriptan—HTR1A—Monoamine GPCRs—CHRM3—nephrolithiasis	0.0059	0.0208	CbGpPWpGaD
Eletriptan—Weight increased—Hydrochlorothiazide—nephrolithiasis	0.00585	0.00848	CcSEcCtD
Eletriptan—Hyperglycaemia—Hydrochlorothiazide—nephrolithiasis	0.0058	0.00841	CcSEcCtD
Eletriptan—Acute coronary syndrome—Hydrochlorothiazide—nephrolithiasis	0.00565	0.00819	CcSEcCtD
Eletriptan—Neuropathy peripheral—Hydrochlorothiazide—nephrolithiasis	0.00562	0.00815	CcSEcCtD
Eletriptan—Myocardial infarction—Hydrochlorothiazide—nephrolithiasis	0.00562	0.00815	CcSEcCtD
Eletriptan—Conjunctivitis—Hydrochlorothiazide—nephrolithiasis	0.00557	0.00808	CcSEcCtD
Eletriptan—Sweating—Hydrochlorothiazide—nephrolithiasis	0.00549	0.00797	CcSEcCtD
Eletriptan—HTR1F—GPCRs, Other—CHRM3—nephrolithiasis	0.00549	0.0194	CbGpPWpGaD
Eletriptan—Epistaxis—Hydrochlorothiazide—nephrolithiasis	0.0054	0.00784	CcSEcCtD
Eletriptan—Sinusitis—Hydrochlorothiazide—nephrolithiasis	0.00538	0.0078	CcSEcCtD
Eletriptan—HTR1F—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00526	0.0186	CbGpPWpGaD
Eletriptan—Bradycardia—Hydrochlorothiazide—nephrolithiasis	0.00524	0.00759	CcSEcCtD
Eletriptan—Rhinitis—Hydrochlorothiazide—nephrolithiasis	0.00516	0.00748	CcSEcCtD
Eletriptan—Hypoaesthesia—Hydrochlorothiazide—nephrolithiasis	0.00512	0.00742	CcSEcCtD
Eletriptan—Pharyngitis—Hydrochlorothiazide—nephrolithiasis	0.00511	0.0074	CcSEcCtD
Eletriptan—Oedema peripheral—Hydrochlorothiazide—nephrolithiasis	0.00507	0.00735	CcSEcCtD
Eletriptan—HTR1E—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00497	0.0175	CbGpPWpGaD
Eletriptan—Visual impairment—Hydrochlorothiazide—nephrolithiasis	0.00496	0.00719	CcSEcCtD
Eletriptan—HTR1A—Amine ligand-binding receptors—CHRM3—nephrolithiasis	0.00496	0.0175	CbGpPWpGaD
Eletriptan—CYP2C19—urine—nephrolithiasis	0.00486	0.179	CbGeAlD
Eletriptan—Tinnitus—Hydrochlorothiazide—nephrolithiasis	0.0048	0.00696	CcSEcCtD
Eletriptan—Flushing—Hydrochlorothiazide—nephrolithiasis	0.00477	0.00692	CcSEcCtD
Eletriptan—Arrhythmia—Hydrochlorothiazide—nephrolithiasis	0.0046	0.00666	CcSEcCtD
Eletriptan—Alopecia—Hydrochlorothiazide—nephrolithiasis	0.00455	0.00659	CcSEcCtD
Eletriptan—Flatulence—Hydrochlorothiazide—nephrolithiasis	0.00441	0.0064	CcSEcCtD
Eletriptan—Tension—Hydrochlorothiazide—nephrolithiasis	0.00439	0.00637	CcSEcCtD
Eletriptan—Dysgeusia—Hydrochlorothiazide—nephrolithiasis	0.00438	0.00636	CcSEcCtD
Eletriptan—Nervousness—Hydrochlorothiazide—nephrolithiasis	0.00435	0.00631	CcSEcCtD
Eletriptan—Back pain—Hydrochlorothiazide—nephrolithiasis	0.00433	0.00628	CcSEcCtD
Eletriptan—Muscle spasms—Hydrochlorothiazide—nephrolithiasis	0.00431	0.00624	CcSEcCtD
Eletriptan—Tremor—Hydrochlorothiazide—nephrolithiasis	0.0042	0.00608	CcSEcCtD
Eletriptan—Ill-defined disorder—Hydrochlorothiazide—nephrolithiasis	0.00415	0.00603	CcSEcCtD
Eletriptan—Anaemia—Hydrochlorothiazide—nephrolithiasis	0.00414	0.006	CcSEcCtD
Eletriptan—Agitation—Hydrochlorothiazide—nephrolithiasis	0.00411	0.00597	CcSEcCtD
Eletriptan—Angioedema—Hydrochlorothiazide—nephrolithiasis	0.00409	0.00593	CcSEcCtD
Eletriptan—Malaise—Hydrochlorothiazide—nephrolithiasis	0.00404	0.00586	CcSEcCtD
Eletriptan—Vertigo—Hydrochlorothiazide—nephrolithiasis	0.00402	0.00583	CcSEcCtD
Eletriptan—Syncope—Hydrochlorothiazide—nephrolithiasis	0.00402	0.00582	CcSEcCtD
Eletriptan—Leukopenia—Hydrochlorothiazide—nephrolithiasis	0.00401	0.00581	CcSEcCtD
Eletriptan—Palpitations—Hydrochlorothiazide—nephrolithiasis	0.00396	0.00574	CcSEcCtD
Eletriptan—Loss of consciousness—Hydrochlorothiazide—nephrolithiasis	0.00394	0.00571	CcSEcCtD
Eletriptan—Cough—Hydrochlorothiazide—nephrolithiasis	0.00391	0.00567	CcSEcCtD
Eletriptan—Arthralgia—Hydrochlorothiazide—nephrolithiasis	0.00381	0.00553	CcSEcCtD
Eletriptan—Myalgia—Hydrochlorothiazide—nephrolithiasis	0.00381	0.00553	CcSEcCtD
Eletriptan—Anxiety—Hydrochlorothiazide—nephrolithiasis	0.0038	0.00551	CcSEcCtD
Eletriptan—CYP2C9—urine—nephrolithiasis	0.00377	0.139	CbGeAlD
Eletriptan—Discomfort—Hydrochlorothiazide—nephrolithiasis	0.00377	0.00546	CcSEcCtD
Eletriptan—Dry mouth—Hydrochlorothiazide—nephrolithiasis	0.00373	0.00541	CcSEcCtD
Eletriptan—Confusional state—Hydrochlorothiazide—nephrolithiasis	0.00368	0.00534	CcSEcCtD
Eletriptan—Oedema—Hydrochlorothiazide—nephrolithiasis	0.00365	0.0053	CcSEcCtD
Eletriptan—Shock—Hydrochlorothiazide—nephrolithiasis	0.0036	0.00521	CcSEcCtD
Eletriptan—Tachycardia—Hydrochlorothiazide—nephrolithiasis	0.00357	0.00517	CcSEcCtD
Eletriptan—HTR7—GPCRs, Other—CHRM3—nephrolithiasis	0.00353	0.0125	CbGpPWpGaD
Eletriptan—Hyperhidrosis—Hydrochlorothiazide—nephrolithiasis	0.00353	0.00512	CcSEcCtD
Eletriptan—Anorexia—Hydrochlorothiazide—nephrolithiasis	0.00348	0.00505	CcSEcCtD
Eletriptan—Hypotension—Hydrochlorothiazide—nephrolithiasis	0.00341	0.00495	CcSEcCtD
Eletriptan—HTR1D—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00337	0.0119	CbGpPWpGaD
Eletriptan—Musculoskeletal discomfort—Hydrochlorothiazide—nephrolithiasis	0.00333	0.00483	CcSEcCtD
Eletriptan—Insomnia—Hydrochlorothiazide—nephrolithiasis	0.00331	0.00479	CcSEcCtD
Eletriptan—HTR1B—G alpha (i) signalling events—RGS14—nephrolithiasis	0.0033	0.0116	CbGpPWpGaD
Eletriptan—Paraesthesia—Hydrochlorothiazide—nephrolithiasis	0.00328	0.00476	CcSEcCtD
Eletriptan—Dyspnoea—Hydrochlorothiazide—nephrolithiasis	0.00326	0.00473	CcSEcCtD
Eletriptan—Somnolence—Hydrochlorothiazide—nephrolithiasis	0.00325	0.00471	CcSEcCtD
Eletriptan—Dyspepsia—Hydrochlorothiazide—nephrolithiasis	0.00322	0.00467	CcSEcCtD
Eletriptan—Decreased appetite—Hydrochlorothiazide—nephrolithiasis	0.00318	0.00461	CcSEcCtD
Eletriptan—Fatigue—Hydrochlorothiazide—nephrolithiasis	0.00315	0.00457	CcSEcCtD
Eletriptan—Pain—Hydrochlorothiazide—nephrolithiasis	0.00313	0.00453	CcSEcCtD
Eletriptan—Constipation—Hydrochlorothiazide—nephrolithiasis	0.00313	0.00453	CcSEcCtD
Eletriptan—Feeling abnormal—Hydrochlorothiazide—nephrolithiasis	0.00301	0.00437	CcSEcCtD
Eletriptan—Gastrointestinal pain—Hydrochlorothiazide—nephrolithiasis	0.00299	0.00433	CcSEcCtD
Eletriptan—Urticaria—Hydrochlorothiazide—nephrolithiasis	0.0029	0.00421	CcSEcCtD
Eletriptan—Body temperature increased—Hydrochlorothiazide—nephrolithiasis	0.00289	0.00419	CcSEcCtD
Eletriptan—Abdominal pain—Hydrochlorothiazide—nephrolithiasis	0.00289	0.00419	CcSEcCtD
Eletriptan—CYP3A4—urine—nephrolithiasis	0.00287	0.106	CbGeAlD
Eletriptan—CYP2D6—urine—nephrolithiasis	0.00283	0.104	CbGeAlD
Eletriptan—Hypersensitivity—Hydrochlorothiazide—nephrolithiasis	0.00269	0.0039	CcSEcCtD
Eletriptan—Asthenia—Hydrochlorothiazide—nephrolithiasis	0.00262	0.0038	CcSEcCtD
Eletriptan—Pruritus—Hydrochlorothiazide—nephrolithiasis	0.00259	0.00375	CcSEcCtD
Eletriptan—CYP2A6—NRF2 pathway—SLC2A9—nephrolithiasis	0.00254	0.00898	CbGpPWpGaD
Eletriptan—HTR7—G alpha (s) signalling events—PTH—nephrolithiasis	0.00252	0.00891	CbGpPWpGaD
Eletriptan—HTR2B—G alpha (q) signalling events—DGKH—nephrolithiasis	0.00251	0.00886	CbGpPWpGaD
Eletriptan—HTR1A—G alpha (i) signalling events—RGS14—nephrolithiasis	0.00251	0.00886	CbGpPWpGaD
Eletriptan—Diarrhoea—Hydrochlorothiazide—nephrolithiasis	0.0025	0.00363	CcSEcCtD
Eletriptan—Dizziness—Hydrochlorothiazide—nephrolithiasis	0.00242	0.0035	CcSEcCtD
Eletriptan—HTR1F—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00239	0.00842	CbGpPWpGaD
Eletriptan—PTGS1—Biological oxidations—SLC26A1—nephrolithiasis	0.00236	0.00833	CbGpPWpGaD
Eletriptan—Vomiting—Hydrochlorothiazide—nephrolithiasis	0.00232	0.00337	CcSEcCtD
Eletriptan—Rash—Hydrochlorothiazide—nephrolithiasis	0.0023	0.00334	CcSEcCtD
Eletriptan—Dermatitis—Hydrochlorothiazide—nephrolithiasis	0.0023	0.00334	CcSEcCtD
Eletriptan—Headache—Hydrochlorothiazide—nephrolithiasis	0.00229	0.00332	CcSEcCtD
Eletriptan—HTR1E—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00225	0.00794	CbGpPWpGaD
Eletriptan—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—DGKH—nephrolithiasis	0.00225	0.00793	CbGpPWpGaD
Eletriptan—CYP2A6—Biological oxidations—SLC26A1—nephrolithiasis	0.00223	0.00787	CbGpPWpGaD
Eletriptan—Nausea—Hydrochlorothiazide—nephrolithiasis	0.00217	0.00315	CcSEcCtD
Eletriptan—HTR1F—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00204	0.00721	CbGpPWpGaD
Eletriptan—HTR1E—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00193	0.00681	CbGpPWpGaD
Eletriptan—HTR2B—G alpha (q) signalling events—CHRM3—nephrolithiasis	0.00182	0.00641	CbGpPWpGaD
Eletriptan—HTR1F—GPCR downstream signaling—RGS14—nephrolithiasis	0.0018	0.00636	CbGpPWpGaD
Eletriptan—HTR1E—GPCR downstream signaling—RGS14—nephrolithiasis	0.0017	0.006	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—RGS14—nephrolithiasis	0.00164	0.00577	CbGpPWpGaD
Eletriptan—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—CHRM3—nephrolithiasis	0.00162	0.00573	CbGpPWpGaD
Eletriptan—HTR1F—GPCR ligand binding—CHRM3—nephrolithiasis	0.00156	0.00549	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—RGS14—nephrolithiasis	0.00154	0.00545	CbGpPWpGaD
Eletriptan—HTR7—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00154	0.00542	CbGpPWpGaD
Eletriptan—HTR1D—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00153	0.00538	CbGpPWpGaD
Eletriptan—HTR1B—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00149	0.00527	CbGpPWpGaD
Eletriptan—HTR1D—kidney—nephrolithiasis	0.00148	0.0543	CbGeAlD
Eletriptan—HTR1E—GPCR ligand binding—CHRM3—nephrolithiasis	0.00147	0.00518	CbGpPWpGaD
Eletriptan—HTR1F—GPCR ligand binding—PTH—nephrolithiasis	0.00142	0.00502	CbGpPWpGaD
Eletriptan—HTR2B—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.0014	0.00495	CbGpPWpGaD
Eletriptan—CYP2C19—Biological oxidations—SLC26A1—nephrolithiasis	0.00136	0.0048	CbGpPWpGaD
Eletriptan—HTR1E—GPCR ligand binding—PTH—nephrolithiasis	0.00134	0.00474	CbGpPWpGaD
Eletriptan—HTR2B—cortex of kidney—nephrolithiasis	0.00134	0.0492	CbGeAlD
Eletriptan—HTR7—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00132	0.00464	CbGpPWpGaD
Eletriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00131	0.00461	CbGpPWpGaD
Eletriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.00128	0.00452	CbGpPWpGaD
Eletriptan—HTR1A—renal system—nephrolithiasis	0.00127	0.0468	CbGeAlD
Eletriptan—CYP2D6—Biological oxidations—SLC26A1—nephrolithiasis	0.00125	0.00442	CbGpPWpGaD
Eletriptan—CYP2C9—Biological oxidations—SLC26A1—nephrolithiasis	0.00124	0.00438	CbGpPWpGaD
Eletriptan—HTR7—renal system—nephrolithiasis	0.00122	0.0448	CbGeAlD
Eletriptan—HTR1F—GPCR downstream signaling—DGKH—nephrolithiasis	0.00122	0.00429	CbGpPWpGaD
Eletriptan—HTR2B—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.0012	0.00424	CbGpPWpGaD
Eletriptan—HTR7—kidney—nephrolithiasis	0.00118	0.0433	CbGeAlD
Eletriptan—HTR7—GPCR downstream signaling—RGS14—nephrolithiasis	0.00116	0.00409	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—RGS14—nephrolithiasis	0.00115	0.00407	CbGpPWpGaD
Eletriptan—HTR1E—GPCR downstream signaling—DGKH—nephrolithiasis	0.00115	0.00405	CbGpPWpGaD
Eletriptan—HTR1A—GPCRs, Class A Rhodopsin-like—CHRM3—nephrolithiasis	0.00114	0.00402	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—ADCY10—nephrolithiasis	0.00114	0.00401	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—RGS14—nephrolithiasis	0.00113	0.00398	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—DGKH—nephrolithiasis	0.0011	0.0039	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—ADCY10—nephrolithiasis	0.00107	0.00378	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—RGS14—nephrolithiasis	0.00106	0.00374	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—RGS14—nephrolithiasis	0.00105	0.00372	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—RGS14—nephrolithiasis	0.00105	0.00369	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—DGKH—nephrolithiasis	0.00104	0.00368	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—RGS14—nephrolithiasis	0.00102	0.00361	CbGpPWpGaD
Eletriptan—HTR7—GPCR ligand binding—CHRM3—nephrolithiasis	0.001	0.00354	CbGpPWpGaD
Eletriptan—HTR1D—GPCR ligand binding—CHRM3—nephrolithiasis	0.000995	0.00351	CbGpPWpGaD
Eletriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—CHRM3—nephrolithiasis	0.000975	0.00344	CbGpPWpGaD
Eletriptan—HTR1B—GPCR ligand binding—CHRM3—nephrolithiasis	0.000975	0.00344	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—RGS14—nephrolithiasis	0.000966	0.00341	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—RGS14—nephrolithiasis	0.000962	0.0034	CbGpPWpGaD
Eletriptan—HTR7—GPCR ligand binding—PTH—nephrolithiasis	0.000916	0.00323	CbGpPWpGaD
Eletriptan—HTR2B—GPCR ligand binding—CHRM3—nephrolithiasis	0.000915	0.00323	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—RGS14—nephrolithiasis	0.000911	0.00322	CbGpPWpGaD
Eletriptan—HTR1D—GPCR ligand binding—PTH—nephrolithiasis	0.00091	0.00321	CbGpPWpGaD
Eletriptan—HTR1B—GPCR ligand binding—PTH—nephrolithiasis	0.000891	0.00315	CbGpPWpGaD
Eletriptan—HTR1F—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00088	0.0031	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—RGS14—nephrolithiasis	0.000859	0.00303	CbGpPWpGaD
Eletriptan—ABCB1—Transmembrane transport of small molecules—CLCN4—nephrolithiasis	0.000844	0.00298	CbGpPWpGaD
Eletriptan—ABCB1—Transmembrane transport of small molecules—CLCN5—nephrolithiasis	0.000844	0.00298	CbGpPWpGaD
Eletriptan—PTGS1—renal system—nephrolithiasis	0.000842	0.0309	CbGeAlD
Eletriptan—HTR2B—GPCR ligand binding—PTH—nephrolithiasis	0.000837	0.00296	CbGpPWpGaD
Eletriptan—HTR1E—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00083	0.00293	CbGpPWpGaD
Eletriptan—CYP3A4—Biological oxidations—SLC26A1—nephrolithiasis	0.000818	0.00289	CbGpPWpGaD
Eletriptan—PTGS1—kidney—nephrolithiasis	0.000814	0.0299	CbGeAlD
Eletriptan—HTR1F—GPCR downstream signaling—PTH—nephrolithiasis	0.000804	0.00284	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—CHRM3—nephrolithiasis	0.000799	0.00282	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—DGKH—nephrolithiasis	0.000783	0.00276	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—RGS14—nephrolithiasis	0.00078	0.00275	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—DGKH—nephrolithiasis	0.000778	0.00275	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—DGKH—nephrolithiasis	0.000762	0.00269	CbGpPWpGaD
Eletriptan—HTR1E—GPCR downstream signaling—PTH—nephrolithiasis	0.000759	0.00268	CbGpPWpGaD
Eletriptan—HTR1E—Signaling by GPCR—CHRM3—nephrolithiasis	0.000753	0.00266	CbGpPWpGaD
Eletriptan—ABCB1—Transmembrane transport of small molecules—SLC26A6—nephrolithiasis	0.000752	0.00265	CbGpPWpGaD
Eletriptan—HTR1A—GPCR ligand binding—CHRM3—nephrolithiasis	0.000742	0.00262	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—ADCY10—nephrolithiasis	0.000731	0.00258	CbGpPWpGaD
Eletriptan—HTR1F—Signaling by GPCR—PTH—nephrolithiasis	0.00073	0.00258	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—ADCY10—nephrolithiasis	0.000727	0.00256	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—DGKH—nephrolithiasis	0.000716	0.00253	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—ADCY10—nephrolithiasis	0.000711	0.00251	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—DGKH—nephrolithiasis	0.000711	0.00251	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—DGKH—nephrolithiasis	0.000706	0.00249	CbGpPWpGaD
Eletriptan—CYP3A4—renal system—nephrolithiasis	0.000703	0.0258	CbGeAlD
Eletriptan—HTR1B—Signaling by GPCR—DGKH—nephrolithiasis	0.000692	0.00244	CbGpPWpGaD
Eletriptan—CYP2D6—renal system—nephrolithiasis	0.000692	0.0254	CbGeAlD
Eletriptan—HTR1E—Signaling by GPCR—PTH—nephrolithiasis	0.000689	0.00243	CbGpPWpGaD
Eletriptan—ABCB1—Transmembrane transport of small molecules—SLC3A1—nephrolithiasis	0.000688	0.00243	CbGpPWpGaD
Eletriptan—ABCB1—Transmembrane transport of small molecules—SLC34A3—nephrolithiasis	0.000688	0.00243	CbGpPWpGaD
Eletriptan—CYP3A4—kidney—nephrolithiasis	0.000679	0.025	CbGeAlD
Eletriptan—HTR1A—GPCR ligand binding—PTH—nephrolithiasis	0.000679	0.0024	CbGpPWpGaD
Eletriptan—CYP2D6—kidney—nephrolithiasis	0.000669	0.0246	CbGeAlD
Eletriptan—HTR2B—Signaling Pathways—ADCY10—nephrolithiasis	0.000668	0.00236	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000653	0.0023	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—DGKH—nephrolithiasis	0.000653	0.0023	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—DGKH—nephrolithiasis	0.00065	0.00229	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—RGS14—nephrolithiasis	0.000622	0.0022	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—RGS14—nephrolithiasis	0.000618	0.00218	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000616	0.00217	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—DGKH—nephrolithiasis	0.000616	0.00217	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—RGS14—nephrolithiasis	0.000605	0.00214	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—DGKH—nephrolithiasis	0.00058	0.00205	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—RGS14—nephrolithiasis	0.000568	0.00201	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000566	0.002	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000562	0.00199	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000551	0.00194	CbGpPWpGaD
Eletriptan—ABCB1—nephron tubule—nephrolithiasis	0.000547	0.0201	CbGeAlD
Eletriptan—HTR1A—Signaling Pathways—ADCY10—nephrolithiasis	0.000542	0.00191	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—GRHPR—nephrolithiasis	0.000532	0.00188	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—DGKH—nephrolithiasis	0.000527	0.00186	CbGpPWpGaD
Eletriptan—ABCB1—Transmembrane transport of small molecules—SLC34A1—nephrolithiasis	0.000521	0.00184	CbGpPWpGaD
Eletriptan—ABCB1—Transmembrane transport of small molecules—SLC22A12—nephrolithiasis	0.000521	0.00184	CbGpPWpGaD
Eletriptan—HTR7—GPCR downstream signaling—PTH—nephrolithiasis	0.000518	0.00183	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—CHRM3—nephrolithiasis	0.000517	0.00183	CbGpPWpGaD
Eletriptan—HTR1D—GPCR downstream signaling—PTH—nephrolithiasis	0.000514	0.00182	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—CHRM3—nephrolithiasis	0.000514	0.00181	CbGpPWpGaD
Eletriptan—HTR1D—Signaling by GPCR—CHRM3—nephrolithiasis	0.000511	0.0018	CbGpPWpGaD
Eletriptan—HTR1B—GPCR downstream signaling—PTH—nephrolithiasis	0.000504	0.00178	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—GRHPR—nephrolithiasis	0.000503	0.00178	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—CHRM3—nephrolithiasis	0.0005	0.00177	CbGpPWpGaD
Eletriptan—ABCB1—renal system—nephrolithiasis	0.000498	0.0183	CbGeAlD
Eletriptan—ABCB1—Transmembrane transport of small molecules—SLC2A9—nephrolithiasis	0.000485	0.00171	CbGpPWpGaD
Eletriptan—ABCB1—Transmembrane transport of small molecules—SLC26A1—nephrolithiasis	0.000485	0.00171	CbGpPWpGaD
Eletriptan—ABCB1—kidney—nephrolithiasis	0.000481	0.0177	CbGeAlD
Eletriptan—PTGS1—Metabolism—AGXT—nephrolithiasis	0.000474	0.00167	CbGpPWpGaD
Eletriptan—HTR2B—GPCR downstream signaling—PTH—nephrolithiasis	0.000473	0.00167	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—CHRM3—nephrolithiasis	0.000472	0.00167	CbGpPWpGaD
Eletriptan—HTR7—Signaling by GPCR—PTH—nephrolithiasis	0.00047	0.00166	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—CHRM3—nephrolithiasis	0.00047	0.00166	CbGpPWpGaD
Eletriptan—ABCB1—cortex of kidney—nephrolithiasis	0.000468	0.0172	CbGeAlD
Eletriptan—HTR1D—Signaling by GPCR—PTH—nephrolithiasis	0.000467	0.00165	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—RGS14—nephrolithiasis	0.000461	0.00163	CbGpPWpGaD
Eletriptan—HTR1B—Signaling by GPCR—PTH—nephrolithiasis	0.000457	0.00161	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—AGXT—nephrolithiasis	0.000449	0.00158	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—CHRM3—nephrolithiasis	0.000445	0.00157	CbGpPWpGaD
Eletriptan—ABCB1—Transmembrane transport of small molecules—ATP6V0A4—nephrolithiasis	0.000432	0.00152	CbGpPWpGaD
Eletriptan—ABCB1—Transmembrane transport of small molecules—SLC7A9—nephrolithiasis	0.000432	0.00152	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—PTH—nephrolithiasis	0.000432	0.00152	CbGpPWpGaD
Eletriptan—HTR2B—Signaling by GPCR—PTH—nephrolithiasis	0.00043	0.00152	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.00042	0.00148	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—DGKH—nephrolithiasis	0.00042	0.00148	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—CHRM3—nephrolithiasis	0.00042	0.00148	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—DGKH—nephrolithiasis	0.000417	0.00147	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000417	0.00147	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000409	0.00144	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—DGKH—nephrolithiasis	0.000409	0.00144	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—PTH—nephrolithiasis	0.000407	0.00144	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—SLC26A1—nephrolithiasis	0.000403	0.00142	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—APRT—nephrolithiasis	0.000403	0.00142	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—DGKH—nephrolithiasis	0.000384	0.00135	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000384	0.00135	CbGpPWpGaD
Eletriptan—HTR1A—GPCR downstream signaling—PTH—nephrolithiasis	0.000384	0.00135	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—SLC26A1—nephrolithiasis	0.000381	0.00135	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—APRT—nephrolithiasis	0.000381	0.00135	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—CHRM3—nephrolithiasis	0.000381	0.00134	CbGpPWpGaD
Eletriptan—HTR1A—Signaling by GPCR—PTH—nephrolithiasis	0.000348	0.00123	CbGpPWpGaD
Eletriptan—ABCB1—Transmembrane transport of small molecules—AQP1—nephrolithiasis	0.000345	0.00122	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—DGKH—nephrolithiasis	0.000311	0.0011	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—ATP6V0A4—nephrolithiasis	0.000311	0.0011	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—GRHPR—nephrolithiasis	0.000307	0.00108	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—CHRM3—nephrolithiasis	0.000304	0.00107	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—CHRM3—nephrolithiasis	0.000302	0.00107	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—GRHPR—nephrolithiasis	0.0003	0.00106	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—CHRM3—nephrolithiasis	0.000295	0.00104	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—AQP1—nephrolithiasis	0.000287	0.00101	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—GRHPR—nephrolithiasis	0.000282	0.000996	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—GRHPR—nephrolithiasis	0.00028	0.000988	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—PTH—nephrolithiasis	0.000278	0.00098	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—CHRM3—nephrolithiasis	0.000278	0.00098	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—PTH—nephrolithiasis	0.000276	0.000974	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—AGXT—nephrolithiasis	0.000274	0.000966	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—AQP1—nephrolithiasis	0.000272	0.000959	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—PTH—nephrolithiasis	0.00027	0.000954	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—AGXT—nephrolithiasis	0.000267	0.000942	CbGpPWpGaD
Eletriptan—PTGS1—Metabolism—CHRM3—nephrolithiasis	0.00026	0.000918	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—PTH—nephrolithiasis	0.000254	0.000896	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—AGXT—nephrolithiasis	0.000252	0.000888	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—AGXT—nephrolithiasis	0.000249	0.00088	CbGpPWpGaD
Eletriptan—CYP2A6—Metabolism—CHRM3—nephrolithiasis	0.000246	0.000868	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—APRT—nephrolithiasis	0.000233	0.000821	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—SLC26A1—nephrolithiasis	0.000233	0.000821	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—SLC26A1—nephrolithiasis	0.000227	0.000801	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—APRT—nephrolithiasis	0.000227	0.000801	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—CHRM3—nephrolithiasis	0.000225	0.000794	CbGpPWpGaD
Eletriptan—HTR1F—Signaling Pathways—SPP1—nephrolithiasis	0.000217	0.000765	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—APRT—nephrolithiasis	0.000214	0.000755	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—SLC26A1—nephrolithiasis	0.000214	0.000755	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—APRT—nephrolithiasis	0.000212	0.000749	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—SLC26A1—nephrolithiasis	0.000212	0.000749	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—PTH—nephrolithiasis	0.000206	0.000727	CbGpPWpGaD
Eletriptan—HTR1E—Signaling Pathways—SPP1—nephrolithiasis	0.000204	0.000721	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—GRHPR—nephrolithiasis	0.000185	0.000651	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—AQP1—nephrolithiasis	0.000166	0.000585	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—AGXT—nephrolithiasis	0.000164	0.000581	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—AQP1—nephrolithiasis	0.000162	0.000571	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—AQP1—nephrolithiasis	0.000152	0.000538	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—AQP1—nephrolithiasis	0.000151	0.000533	CbGpPWpGaD
Eletriptan—CYP2C19—Metabolism—CHRM3—nephrolithiasis	0.00015	0.000529	CbGpPWpGaD
Eletriptan—ABCB1—Metabolism—CHRM3—nephrolithiasis	0.000146	0.000516	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—SLC26A1—nephrolithiasis	0.00014	0.000494	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—APRT—nephrolithiasis	0.00014	0.000494	CbGpPWpGaD
Eletriptan—HTR7—Signaling Pathways—SPP1—nephrolithiasis	0.000139	0.000492	CbGpPWpGaD
Eletriptan—HTR1D—Signaling Pathways—SPP1—nephrolithiasis	0.000139	0.000489	CbGpPWpGaD
Eletriptan—CYP2D6—Metabolism—CHRM3—nephrolithiasis	0.000138	0.000487	CbGpPWpGaD
Eletriptan—CYP2C9—Metabolism—CHRM3—nephrolithiasis	0.000137	0.000482	CbGpPWpGaD
Eletriptan—HTR1B—Signaling Pathways—SPP1—nephrolithiasis	0.000136	0.000479	CbGpPWpGaD
Eletriptan—HTR2B—Signaling Pathways—SPP1—nephrolithiasis	0.000127	0.00045	CbGpPWpGaD
Eletriptan—HTR1A—Signaling Pathways—SPP1—nephrolithiasis	0.000103	0.000365	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—AQP1—nephrolithiasis	9.97e-05	0.000352	CbGpPWpGaD
Eletriptan—CYP3A4—Metabolism—CHRM3—nephrolithiasis	9.01e-05	0.000318	CbGpPWpGaD
